{
    "title": "MARKET REPORT: Segro plunges 10% after analysts downgrade the Footsie warehouse giant as online shopping boom fizzles out",
    "url": "https://www.dailymail.co.uk/money/markets/article-10779291/MARKET-REPORT-Segro-plunges-10-online-shopping-boom-fizzles-out.html",
    "date": "2022-05-03",
    "keywords": [
        "cent",
        "stock",
        "company",
        "bank",
        "market",
        "fund",
        "property",
        "dividend",
        "world",
        "growth",
        "price",
        "value",
        "time",
        "investing",
        "brexit",
        "rating",
        "ftse",
        "energy",
        "share",
        "opportunity",
        "manager",
        "recovery",
        "way",
        "bounce",
        "income",
        "investment",
        "house",
        "kepler",
        "cheuvreux",
        "hold",
        "target",
        "demand",
        "change",
        "interest",
        "inflation",
        "bp",
        "money",
        "diy",
        "reserve",
        "tomorrow",
        "firm",
        "food",
        "forecast",
        "year",
        "economy",
        "commodity",
        "trading",
        "pressure",
        "oil",
        "tax",
        "result",
        "auction",
        "platform",
        "show",
        "planet",
        "boost",
        "slater",
        "election",
        "coronavirus",
        "uk",
        "risk",
        "isa",
        "account",
        "fee",
        "segro",
        "downgrade",
        "analyststhe",
        "move",
        "warehouse",
        "week",
        "twin",
        "fortune",
        "boom",
        "shopping",
        "warehousesthe",
        "portfolio",
        "sharewarehouse",
        "storage",
        "space",
        "delivery",
        "battle",
        "index",
        "equity",
        "buyer",
        "petrol",
        "city",
        "call",
        "cut",
        "article",
        "decade",
        "percentage",
        "today",
        "england",
        "watch",
        "cancer",
        "drugthe",
        "surufatinib",
        "drug",
        "administration",
        "trial"
    ],
    "category": [
        "money",
        "markets"
    ]
}